Teva Pharmaceutical Industries Limited (NYSE:TEVA) announced a quarterly dividend on Monday, August 7th, Wall Street Journal reports. Shareholders of record on Tuesday, August 29th will be paid a dividend of 0.085 per share on Thursday, September 14th. This represents a $0.34 dividend on an annualized basis and a yield of 1.83%. The ex-dividend date of this dividend is Friday, August 25th.

Teva Pharmaceutical Industries Limited has increased its dividend payment by an average of 2.1% annually over the last three years. Teva Pharmaceutical Industries Limited has a dividend payout ratio of 24.8% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Teva Pharmaceutical Industries Limited to earn $4.27 per share next year, which means the company should continue to be able to cover its $1.16 annual dividend with an expected future payout ratio of 27.2%.

Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) traded down 9.76% during mid-day trading on Monday, reaching $18.59. 85,126,455 shares of the company’s stock were exchanged. The stock has a market cap of $18.89 billion, a price-to-earnings ratio of 238.33 and a beta of 0.46. The stock’s 50-day moving average is $32.05 and its 200-day moving average is $32.28. Teva Pharmaceutical Industries Limited has a 52-week low of $18.50 and a 52-week high of $55.45.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) last released its quarterly earnings data on Thursday, August 3rd. The company reported $0.99 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.06 by $0.07. Teva Pharmaceutical Industries Limited had a negative net margin of 25.18% and a positive return on equity of 15.96%. The company had revenue of $5.69 billion during the quarter, compared to analyst estimates of $5.72 billion. During the same quarter in the prior year, the firm earned $1.25 earnings per share. Teva Pharmaceutical Industries Limited’s revenue for the quarter was up 12.9% on a year-over-year basis. On average, equities analysts expect that Teva Pharmaceutical Industries Limited will post $4.44 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Teva Pharmaceutical Industries Limited (NYSE:TEVA) Announces $0.09 Quarterly Dividend” was originally published by American Banking News and is the property of of American Banking News. If you are reading this news story on another publication, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/08/07/teva-pharmaceutical-industries-limited-nyseteva-announces-0-09-quarterly-dividend.html.

Several research firms have commented on TEVA. Barclays PLC decreased their price objective on shares of Teva Pharmaceutical Industries Limited from $38.00 to $23.00 and set an “equal weight” rating on the stock in a report on Monday. Piper Jaffray Companies reiterated a “hold” rating and issued a $23.00 price objective on shares of Teva Pharmaceutical Industries Limited in a report on Friday. Cantor Fitzgerald set a $27.00 price objective on shares of Teva Pharmaceutical Industries Limited and gave the company a “hold” rating in a report on Thursday. Sanford C. Bernstein downgraded shares of Teva Pharmaceutical Industries Limited from an “outperform” rating to a “market perform” rating in a report on Friday. Finally, Maxim Group reiterated a “hold” rating and issued a $35.00 price objective on shares of Teva Pharmaceutical Industries Limited in a report on Friday. One investment analyst has rated the stock with a sell rating, twenty-two have given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $39.19.

About Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops, manufactures and sells generic medicines in a range of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams.

Dividend History for Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Receive News & Ratings for Teva Pharmaceutical Industries Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teva Pharmaceutical Industries Limited and related companies with MarketBeat.com's FREE daily email newsletter.